SCHEMBL4929904

SCHEMBL4929904

C[C@@H](NC(=O)c1ccc(-c2ccnc(N)n2)s1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 5/20 0.57
HDAC4 P56524 5/20 0.57
HDAC1 Q13547 5/20 0.57
HDAC6 Q9UBN7 5/20 0.56
ROCK1 Q13464 3/20 0.49
CHEK1 O14757 1/20 0.48
AURKA O14965 1/20 0.48
MAP4K4 O95819 1/20 0.48
PRKACA P17612 1/20 0.48
GRK5 P34947 1/20 0.48
CSNK1A1 P48729 1/20 0.48
CDK8 P49336 1/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
RPS6KA3 P51812 1/20 0.48
PRKX P51817 1/20 0.48
PRKCQ Q04759 1/20 0.48
ACVR1 Q04771 1/20 0.48
AURKB Q96GD4 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924499 1.00 HDAC3 (0.57) HDAC3HDAC4HDAC1HDAC6ROCK1
SCHEMBL4925329 0.88 ROCK1 (0.52) HDAC3HDAC4HDAC1HDAC6ROCK1
SCHEMBL4929103 0.87 ROCK1 (0.48) HDAC3HDAC4HDAC1HDAC6ROCK1
SCHEMBL4927755 0.85 ROCK1 (0.52) ROCK1AKT3ALDH1A1HPGDSKDM4E
SCHEMBL4931327 0.85 ROCK1 (0.52) ROCK1AKT3ALDH1A1HPGDSKDM4E
SCHEMBL4929158 0.85 ROCK1 (0.70) ROCK1CHEK1AURKAMAP4K4PRKACA
SCHEMBL4927771 0.85 ROCK1 (0.70) ROCK1CHEK1AURKAMAP4K4PRKACA
SCHEMBL4923121 0.85 ROCK1 (0.70) ROCK1CHEK1AURKAMAP4K4PRKACA
SCHEMBL13992686 0.84 AKT3 (0.52) AKT3MAPTCDC7LMNA
SCHEMBL4990803 0.84 AKT3 (0.52) AKT3MAPTCDC7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293716-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION (US) 2008-11-27 US disclosed
EP-1708697-A4 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-11-28 EP disclosed
EP-1708697-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-11 EP disclosed
WO-2005074642-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293716-A1 Chemical Compounds CYP11B2, CYP11B1, REN HDAC3 201/4885HDAC4 943/4885HDAC1 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.